Form 4: Inotiv Inc. Executive John Sagartz Receives Stock Grant

John Sagartz, Chief Strategy Officer at Inotiv, Inc., reports the acquisition of 30,000 shares of common stock through a restricted stock unit grant.

Summary

• John Sagartz, Chief Strategy Officer of Inotiv, Inc., filed a Form 4 on March 18, 2025, reporting a transaction.
• On March 14, 2025, Sagartz acquired 30,000 shares of Inotiv common stock through a grant of restricted stock units.
• These restricted stock units vest in full on March 14, 2027, contingent upon continued employment.
• Following this transaction, Sagartz beneficially owns 737,816 shares of Inotiv common stock directly.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The stock grant is a positive sign of aligning executive interests with shareholder value, but it's a routine transaction.

Positives

• The grant of restricted stock units to a key executive like the Chief Strategy Officer can align their interests with the long-term success of the company.
• The vesting schedule tied to continued employment incentivizes the executive to remain with the company.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Stock grants are a common form of executive compensation in publicly traded companies, particularly in the biotech and pharmaceutical services industries. They are used to incentivize executives and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages in the pharmaceutical and biotechnology industries.
• Companies like Charles River Laboratories and Envigo (now part of Inotiv) also utilize stock grants as part of their compensation strategy for key executives.
• The vesting schedule of two years is fairly standard, aligning with typical retention incentives.

Stakeholder Impact

• Shareholders may view the stock grant positively as it aligns executive interests with company performance.
• Employees may see it as a positive sign of the company investing in its leadership.

Key Dates